Dr. Dimitra Ioanna Lampropoulou holds an MSc in Clinical Pharmacy (School of Pharmacy) and PhD in Cancer Pharmacogenomics from the National and Kapodistrian University of Athens (NKUA, School of Medicine). Since 2021, she has been actively involved as a Scientific Collaborator of Professor Gazouli (NKUA, School of Medicine) in several research projects. Her scientific output includes more than 20 publications in pubmed-indexed journals. She has extensive experience in clinical research (including the regulatory framework as well as the overall conduct of clinical trials). Dr Lampropoulou has also served as a designated member of the Committee for the Medical Information and Advertising Control at EOF (2020-2022). Following the completion of the relevant Pharmacovigilance training and assessment by the European Medicines Agency (EMA) combined with her considerable experience, she also holds the title of Pharmacovigilance Specialist. She has been an invited speaker/chairperson/ member of the scientific and organizing Committees in several national and international congresses. The scope of her work includes Clinical Operations, Study Design, PV, Medical Writing, Regulatory and Medical Affairs.

Dr. Gerasimos Aravantinos, Medical Oncologist, PhD, is currently the Director of the 4th Oncology Department of the private hospital “Euroclinic Athens”. He has served as as the Scientific Director in the 2nd Department of Medical Oncology, General Oncology Hospital of Kifissia “Agioi Anargiroi”, Athens (2011-2022), and Deputy Director at the 3rd Department of Medical Oncology, G.O.H.K “Agioi Anargiroi”, Athens (2006-2011). Dr Aravantinos has extensive experience in Clinical Research and has been the Principal Investigator in more than 90 interventional and non-interventional international oncology clinical trials. He also has been a member of the Board of Directors of the Hellenic Society of Medical Oncology for several years (1999-2017). Furthermore, he has erved as a designated member of the National Ethics committee of National Organization for Medicines (EED) from 2001 to 2009. He has been an Adjunct Professor in Clinical Oncology at the Clinical Pharmacy Masters Diploma (NKUA) (2005-2017). He has authored and co-authored more than 220 articles in peer-reviewed journals (Scopus, h-Index=43). He is also a member/founding member of more than 10 National Medical Professional bodies. Board Certified Member of ESMO since 1993 and full member of ASCO since 1999. He currently collaborates with ECONCARE as Medical Consultant in the Clinical Research Department.

Garyfallia Stefanou studied Applied Mathematics at the National Kapodistrian University of Athens and earned her MSc in Biostatistics with honors from the same university. She worked as a statistician consultant at the National School of Public Health and the University of Thessaly. During her dissertation, she volunteered as a research fellow at the Medical School of Athens. Earlier, she assisted in data management at the Hellenic Institution of Osteoporosis and was a mathematics tutor. She has published in reputable journals and participated in numerous conferences. Currently, she is Head of Biostatistics and Programming at ECONCARE, specializing in statistical analysis of healthcare data, cost-of-illness studies, observational studies, surveys, meta-analyses, sample size estimations, and clinical study development. Her interests include medical cost data analysis, Bayesian approaches, and decision analysis models. She is proficient in R, STATA, and SPSS.

Katerina Vellopoulou holds the position of Consultant, Senior Health Economist at ECONCARE. Following studies in ‘Health Economics, Policy and Law’ in Erasmus University Rotterdam, she started her career as a Data Analyst in HEOR of IMS Health, Belgium. Her long-term experience extends to a broad spectrum of diseases: oncology, endocrinology, autoimmune disorders, neurology, ophthalmology. She gained thorough expertise on Health Economic Modelling (Markov Models & Decision Analytic trees), Cost-Effectiveness, Budget Impact Analyses, Cost of illness Studies, Systematic Literature Reviews and also Advisory Boards, and has accomplished various HTA submissions at international level. She can support the business case strategy for an intervention entering the Greek market from the early stage until Negotiation Strategy, including meetings both with the HTA and Negotiation committee. Katerina holds a BSc in Economics from the National and Kapodistrian University of Athens. Katerina has a proficient level of English and French and good level of Spanish.

Maria Koulentaki is a consultant at ECONCARE, specializing in Health Economics Outcomes Research (HEOR) and Market Access, including HTA submissions and Pricing. She excels in developing decision-analytic models like cost-effectiveness, cost-comparison, and budget impact models. Maria collaborates with pharmaceutical companies' medical, market access, and commercial teams to design and execute HEOR strategies, investigating patient burden, economic impact, unmet needs, and outcomes. Her expertise includes organizing Advisory Boards, conducting Systematic Literature Reviews (SLR), evidence synthesis, and documenting full economic evaluation reports, as well as understanding pricing and reimbursement regulations in Greece and Cyprus. Maria holds a BSc in Management and Business Administration from the Athens University of Economics and Business and an MSc in Health Services Administration from the University of West Attica. She has extensive experience in various therapeutic areas, including cardiology, oncology, and rheumatology, and in different therapeutic categories, such as generics, biologics, and biosimilars.

Foteini Gialama is a medical writer at ECONCARE. She has extensive experience in synthesizing biomedical data, in conducting systematic literature reviews and literature-based regulatory submission documents and in scientific writing having published her work in several international peer-reviewed journals. As a medical writer in ECONCARE her main experience and expertise include the development of reimbursement/health technology assessment (HTA) dossiers for several medical technologies in a wide range of therapeutic areas. 

Foteini holds a B.Sc. in Human Resources Management from the National and Kapodistrian University of Athens (NKUA) in Greece and two MSc degrees, one in Health Information Systems from the University of Brunel in London and the other in Health Management from the University of Piraeus in Athens, Greece. She earned her PhD in Health Workforce Policy & Planning from the University of Peloponnese, in Korinthos, Greece.

Katerina Lioliou, MPharm, MSc, is a graduate of the School of Pharmacy at the National and Kapodistrian University of Athens (NKUA) and holds a master's degree from the School of Medicine’s program “Development of New Drugs: Research, Circulation, and Access,” with an “Excellent” grade. Her thesis, “Do neurosteroids have a neuroprotective role in an in vitro model of Parkinson's disease?” was conducted at the University of Modena and Reggio Emilia (UNIMORE), also earning an “Excellent” grade.

Currently, Katerina works as a Medical Writer at ECONCARE, Health Research & Consulting. She has extensive experience in developing clinical dossiers for the Health Technology Assessment Committee (HTA) in Greece and Cyprus and offers consulting services to the pharmaceutical industry. She designs study protocols, writes scientific articles, and contributes as an educator and invited lecturer at NKUA. Additionally, Katerina holds a certificate in Medical Devices Regulatory Requirements and has four years of experience as a community pharmacist.

George Gounelas studied Mathematics at University of Patras and continued his studies in MSc Biostatistics at National and Kapodistrian University of Athens. He volunteered in data collection for use in epidemic analysis of SARS-COV2 during the pandemic. Earlier in his career, he was a Mathematics and Statistics tutor. His area of expertise includes statistical analysis of data from observational studies, monitoring and analysis of clinical trials and evidence synthesis. Currently, he is appointed as a Biostatistician at ECONCARE, a research and consulting firm. His interests include machine learning techniques, such as decision trees and neural networks, for statistical predictions and forecasting, database management and epidemic models. He also has experience working with R, STATA, Python, SPSS and SQL.

Stelios Ravanidis holds the position of medical writer at ECONCARE with a particular focus in the preparation of HTA dossiers and scientific material. His extensive basic research experience lies mainly in neurodegenerative disorders, such as multiple sclerosis and Parkinson’s disease. Stelios is experienced in literature-based reviews and scientific writing, having his work published in international peer-reviewed journals (h-index: 11). He has also been involved in the participation in consortia for research grant applications, the scientific communication of his work while he has served as an ad hoc reviewer and guest editor in PubMed-indexed journals. Stelios holds a B.Sc. in Molecular Biology and Genetics from the Democritus University of Thrace in Greece and two MSc degrees, one in Applied Genetics and Biotechnology from the Aristotle University of Thessaloniki and the other in Political Sciences and History from the Panteion University of Social and Political Sciences in Athens, Greece. He earned his PhD in Biomedical Sciences from the Hasselt University, Hasselt, Belgium.

Myriam Paspalaki is a Pharmacist graduated from School of Pharmacy, National & Kapodistrian University of Athens (NKUA). The completion of her MSc studies in “Clinical Trials: Design & Conduct” (Medical School, NKUA) has offered her thorough training in both the theoretical and practical aspects of clinical trials. More specifically, she has gained a deeper insight in clinical trial design, data management and analysis, the current regulatory and ethical framework and different types of trials and study populations. Her thesis focused on the comparison of GLP-1 analogues in the Management of Diabetes Mellitus. She has worked as a Responsible Pharmacist in a large Community Pharmacy for several years acquiring extensive knowledge in Primary Healthcare, in the context of Pharmaceutical Care. Myriam has also worked as a Hospital Pharmacist Intern at Andreas Syngros Hospital of Venereal & Dermatological Diseases and University Hospital of Heraklion. She currently works as a Clinical Trials Associate (CRA) in Econcare.

Figaleia Karathanou is a graduate of the Chemistry Department of the National & Kapodistrian University of Athens (NKUA). She also holds an MBA in "Health Economics and Health Services Management" from the Department of Economics of the NKUA. Currently, Figaleia works as a consultant at ECONCARE, specializing in Health Economics Outcomes Research (HEOR) and Market Access business areas, including HTA submissions and Pricing. Additionally, she has ten years of experience in community pharmacy.

Figaleia has experience in fields such as Pharmaceutical Product Authorization, Pricing, Health Technology Assessment, Policies for public pharmaceutical spending, and public health. She excels at managing projects across Health Economics Outcomes Research (HEOR) and has specialty knowledge in the field of Legislation and regulatory framework in the areas of Medicines, Medical Devices, and Foods for Special Medical Purposes.